HEC Lausanne

The New Germany Fund, Inc. Announces Portfolio Manager Changes

Retrieved on: 
Monday, January 30, 2023
Asset Management, Professional Services, Finance, Master of Science, War, GF, Coronavirus, DWS, Investment, NYSE, Heinrich Heine University Düsseldorf, HEC Lausanne, DWS Group, Nature, Terrorism, Sale, University, Fund, Bachelor of Science, University of Mannheim Business School, Security (finance), Bank, Economics

The New Germany Fund, Inc. (NYSE: GF) (the “Fund”) announced today that Leon Cappel will replace Valerie Schueler as the Fund’s portfolio manager effective March 1, 2023.

Key Points: 
  • The New Germany Fund, Inc. (NYSE: GF) (the “Fund”) announced today that Leon Cappel will replace Valerie Schueler as the Fund’s portfolio manager effective March 1, 2023.
  • Mr. Cappel currently serves as the Fund’s deputy portfolio manager and has been a member of the Fund’s portfolio management team since 2022.
  • In addition, effective March 1, 2023, Alexander Lippert will replace Mr. Cappel as the Fund’s deputy portfolio manager.
  • The New Germany Fund, Inc. is diversified, but primarily focuses its investments in Germany, thereby increasing its vulnerability to developments in that country.

Insigneo Adds Mauricio Viaud as Senior Investment Strategist and Portfolio Manager

Retrieved on: 
Thursday, January 5, 2023
Consulting, Professional Services, Finance, Janney, SMA, BNY Mellon, Bank, CFA, Level 2, Research, Business, Multimedia, Publication, Level, University of Richmond, Viaud, University, Radio, Carnegie Mellon Silicon Valley, CIO, Tepper School of Business, Financial Times, Management, Financial services, HEC Lausanne

Insigneo , a leading international wealth management firm, today announced the hiring of Mauricio Viaud as Senior Investment Strategist & Portfolio Manager.

Key Points: 
  • Insigneo , a leading international wealth management firm, today announced the hiring of Mauricio Viaud as Senior Investment Strategist & Portfolio Manager.
  • View the full release here: https://www.businesswire.com/news/home/20230105005749/en/
    Mauricio Viaud: Senior Investment Strategist and Portfolio Manager (Photo: Business Wire)
    Prior to joining the firm, Viaud worked as a Senior Equity Research Analyst at Janney, Montgomery, Scott, where he provided equity research insight and analysis for global stock portfolios.
  • He also has significant experience providing equity research for institutional mutual funds, writing equity research reports, formulating investment strategy as a member of various strategy committees, and executing portfolio management responsibilities.
  • "I am thrilled to join Insigneo and consider it a natural next step in my career,” Viaud said.

AC Immune Reports Changes to Senior Management

Retrieved on: 
Friday, April 8, 2022
People, Ernst, Neurodegeneration, CH, SEC, Interim management, CEO, Hotel manager, NO, AC, Time, GLOBE, HR, Janssen Pharmaceuticals, SGS S.A., SOX, Business administration, Director, GB, Eli Lilly and Company, Christian Social People's Service, IPO, Lancaster University, Treasury, National Executive Committee of the Labour Party, IFRS, BDO, NASDAQ, Interim, Form, Genentech, Board, CFO, RU, Precision medicine, Form 6-K, World Economic Forum, AU, Financial statement, Reward, Puma Energy, Patient, Form 20-F, HEC Lausanne, Company, Xerox, Automation, Compliance, SG, Associate, Snow, Communication, Corporate development, Hoffmann-La Roche, PCAOB, MBA, R, Executive Committee, Acquisition, Management, Accounting, Finance, Science, EU

LAUSANNE, Switzerland, April 08, 2022 (GLOBE NEWSWIRE) -- AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced senior management changes. Howard Donovan will join the Company as Chief HR Officer and be appointed to the Executive Committee. Joerg Hornstein, Chief Financial Officer, will leave in the second half to pursue a new opportunity. Christopher Roberts, Associate Vice President, Finance, was promoted to Vice President, Finance and appointed interim CFO. Julian Snow, Associate Vice President, Financial Reporting, was promoted to Vice President, U.S. Finance & Corporate Development.

Key Points: 
  • These changes allow us to further develop and optimize our internal HR and finance functions as we continue to build a stronger, more robust AC Immune team.
  • He worked as a Senior Manager for Ernst and Young and supported the AC Immune IPO.
  • SupraAntigenis a registered trademark of AC Immune SA in the following territories: AU, EU, CH, GB, JP, RU and SG.
  • Morphomer is a registered trademark of AC Immune SA in CN, CH, GB, JP, NO and RU.